亚洲熟女av综合网五月,两个人高清在线观看www视频,亚洲精品tv久久久久久久久久,爱如潮水日本免费完整版观看,国产精品99久久久久久董美香 ,三年片免费观看国语,亚洲一区二区三区 日韩 ,波多野结系列18部无码观看a
首頁 > 中山大學附屬腫瘤醫院 > 內科 駱卉妍

駱卉妍主治醫師

中山大學附屬腫瘤醫院內科

執業經歷

出生日期:1977年10月 工作單位:中山大學腫瘤防治中心內科 通信地址:廣州市東風東路651號 510060 E-mail: luohy@sysucc.org.cn 聯系電話:020-87342490 教育背景: 1995.09~2000.07 廣西醫科大學臨床醫學系醫學學士 2004.09~2007.06中山大學附屬腫瘤醫院腫瘤學碩士 2007.07~2010.07 中山大學附屬腫瘤醫院腫瘤學專科培訓醫師 2012.09~2015.6中山大學腫瘤學和生物醫學工程聯合培養博士 2015.6~至今美國加州大學圣地亞哥分校訪問學者 工作經歷: 2000.08~2004.08.作為住院醫師在桂林醫學院附屬醫院呼吸內科工作 2004.09~2007.06中山大學附屬腫瘤醫院攻讀臨床型腫瘤學碩士研究生 2007.07~2010.07 中山大學附屬腫瘤醫院接受腫瘤學專科醫師培訓 2010.-8至今作為主治醫師在中山大學附屬腫瘤醫院內科工作 研究方向: 主要從事消化道腫瘤的化學治療和靶向治療,以及腫瘤耐藥和克服耐藥的基礎和轉化性研究。作為徐瑞華教授課題組主要研究人員參與國家自然科學基金項目、廣東省自然科學基金項目、廣州市科技計劃項目等多項科研課題,參與和完成多項I、II、III期臨床研究。在國內外期刊發表文章50余篇,并以第一作者在Clin Cancer Res,J Cancer Res, Clin Oncol等雜志上發表SCI論文7篇。此外,還以第一作者發表綜述6篇,其中兩篇被2007年、2014年CSCO大會收錄。 承擔科研項目: 1)項目名稱:“新型聚氨酯納米材料載體克服奧沙利鉑耐藥的研究”,項目編號:(A2014251),廣東省醫學科研基金項目,時間是2014年-2016年。項目負責人。 2)項目名稱:“Bmal1基因對結腸癌細胞生長的作用及機制研究”,項目編號:(81000888),國家自然科學基金青年基金項目,時間是2011年-2014年。第三負責人。 3)項目名稱:“microRNA-214在結腸癌肝轉移中的作用及機制研究”,項目編號:(81372570),國家自然科學基金面上項目,時間是2014年-2017年。第四負責人。 4) 項目名稱:“活性氧/NFkB 信號通路在腦膠質瘤干細胞分化中的作用及其調控機制”,項目編號:(81302194),國家自然科學基金青年基金項目,時間是2014年-2016年。第五負責人,負責數據的分析。 主要發表論文: 1. Zeng ZL, Luo HY(co-first author), Yang J, Wu WJ, Chen DL, Huang P, Xu RH*. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.Clin Cancer Res. Feb 15;20(4):1042-52, 2014. (SCI 8.77) 2. Luo HY, Xu RH.Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.World J Gastroenterol. 2014 Apr 14;20(14):3858-74.(SCI 2.65) 3. Zhang Y, Luo HY(co-first author), Liu GL, Wang DS, Wang ZQ, Zeng ZL, Xu RH*. Prognostic significance and therapeutic implications of peroxisome proliferator-activated receptor overexpression in human pancreatic carcinoma.Int J Oncol. 2014 Oct 17. doi: 10.3892/ijo.2014.2709. (SCI 3.025) 4. Luo HY, Wang ZQ, Wang FH, Qiu MZ, Teng KY, Ruan DY, He YJ, Li YH, Xu RH*. Phase II study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer. Am J Clin Oncol. Dec;34(6):555-60, 2011. (SCI 3.06) 5. Luo HY, Wei W, Shi YX, Chen XQ, Li YH, Wang F, Qiu MZ, Li FH, Yan SL, Zeng MS, Huang P, Xu RH*. Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines. Oncol Rep. Jun;23(6):1735-45. 2010. (SCI 2.30) 6. Luo HY,Xu RH*, Wang F, Qiu MZ, Li YH, Li FH, Zhou ZW, Chen XQ. Phase II trial of XELOX as first-line treatment for patients with unresectable or metastatic gastric cancer. Chemotherapy. 56(2):94-100. 2010 (SCI 1.28) 7. Li YH, Luo HY(co-first author),Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH*. Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer. J Cancer Res Clin Oncol.Apr;136(4):503-10. 2010 (SCI 3.09) 8. Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, Wang FH, Chiao LJ, Pelicano H, Huang P, Li YH, Xu RH. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.Hepatology. 2014 Aug;60(2):598-609. (SCI 11.19) 9. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.Carcinogenesis. 2013 Apr;34(4):803-11. (SCI 5.26) 10. An X, Wang F, Shao Q, Wang FH, Wang ZQ, Wang ZQ, Chen C, Li C, Luo HY, Zhang DS, Xu RH, Li YH. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.Cancer. 2014 Mar 1;120(5):675-82. Epub 2013 Nov 5. 11. Chen WW, Wang F, Zhang DS, Luo HY, Wang ZQ, Wang FH, Qiu MZ, Ren C, Wei XL, Wu WJ, Li YH, Xu RH. Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.BMC Cancer. 2014 Mar 25;14:222. doi: 10.1186/1471-2407-14-222 12. Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH*. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.Med Oncol. Dec;29(5):3092-100.2012 (SCI 2.14) 13. Dai SQ, An X, Wang F, Shao Q, Chen YC, Kong YN, Chen C, Li C, Luo HY, Liang Y, Wang FH, Xu RH, Li YH*. Serum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinoma.PLoS One. May 14;8(5):e63458.2013 (SCI 3.73) 14. Qiu MZ, Wang ZQ, Zhang DS, Liu Q, Luo HY, Zhou ZW, Li YH, Jiang WQ, Xu RH *. Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China.Ann Surg Oncol. Jul;18(7):1869-76. 2011 (SCI 4.18) 15. Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, Wang FH, Li YH, Zhou ZW, Xu RH*. Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. J Transl Med. Jan 27;10:16, 2012 . (SCI 3.45) 16. Chen DL, Wang ZQ, Ren C, Zeng ZL, Wang DS, Luo HY, Wang F, Qiu MZ, Bai L, Zhang DS, Wang FH, Li YH, Xu RH*. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.J Transl Med. Nov 2;11:277. 2013 (SCI 3.45) 17. He MM, Zhang DS, Wang F, Wang ZQ, Luo HY, Jin Y, Wei XL, Xu RH*. The role of non-curative surgery in incurable, asymptomatic advanced gastric cancer.PLoS One. Dec 16;8(12):e83921. 2013 (SCI 3.73) 18. He MM, Zhang DS, Wang F, Wang ZQ, Luo HY, Ren C, Jin Y, Chen DL, Xu RH*. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.World J Gastroenterol. Jan 7;20(1):264-73.2014 (SCI 2.55) 19. Li ZH, Qiu MZ, Zeng ZL, Luo HY, Wu WJ, Wang F, Wang ZQ, Zhang DS, Li YH, Xu RH*. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). J Transl Med. 2012 Feb 3;10(1):21. 20. Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH*. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer.Tumour Biol. 2011 Dec 24 21. Qiu HB, Chen G, Keshari RP, Luo HY, Fang W, Qiu MZ, Zhou ZW, Xu RH*. The extramural metastasis might be categorized in lymph node staging for colorectal cancer. BMC Cancer. 2011 Sep 26;11(1):414. 22. Wang DS, Zhang DS, Qiu MZ, Wang ZQ, Luo HY, Wang FH, Li YH, Xu RH*. Prognostic factors and survival in patients with neuroendocrine tumors of the pancreas. Tumour Biol. 2011 Aug;32(4):697-705. 23. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH*. ABO blood group, hepatitis B viral infection, and risk of pancreatic cancer. Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26376. 24. Qiu MZ, Wang ZQ, Zhang DS, Liu Q, Luo HY, Zhou ZW, Li YH, Jiang WQ, Xu RH*. Prognostic analysis in node-negative gastric cancer patients in China. Tumour Biol. 2011 Jul;18(7):1869-76. Epub 2011 Jan 19. 25. Qiu MZ, Wang ZQ, Luo HY, Zhang DS, Zhou ZW, Li YH, Jiang WQ, Xu RH*. Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China. Tumour Biol. 2011 Jun;32(3):509-14. 26. Qiu HB, Zhang LY, Zeng ZL, Wang ZQ, Luo HY, Keshari RP, Zhou ZW, Xu RH*. HBV infection decreases risk of liver metastasis in patients with colorectal cancer: A cohort study. World J Gastroenterol. 2011 Feb 14;17(6):804-8. 27. Teng KY, Qiu MZ, Li ZH, Luo HY, Zeng ZL, Luo RZ, Zhang HZ, Wang ZQ, Li YH, Xu RH*. DNA polymeraseeta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J Transl Med. 2010 Nov 27;8(1):126 28. Li FH, Shen L, Li ZH, Luo HY, Qiu MZ, Zhang HZ, Li YH, Xu RH*. Impact of KRAS mutation and PTEN expression cetuximab-treated colorectal cancer. W J of Gastroenterology 2010 Dec 14:16(46):5881-5888. 29. Qiu MZ, Xu RH*, Ruan DY, Li ZH, Luo HY, Teng KY, Wang ZQ, Li YH, Jiang WQ. Ruan DY et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol.2010 Dec;31(6):633-41. 30. Qiu MZ, Yuan ZY, Luo HY, Ruan DY, Wang ZQ, Wang FH, Li YH, Xu RH*. Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol. 2010 Aug;31(4):255-60

擅長領域

腫瘤內科治療的臨床工作及轉化研究?

其他相同科室醫生

韓寶德主任醫師

汾陽市中醫院 · 內科

擅長:腫瘤內科治療的臨床工作及轉化研究?

靳明麗主任醫師

長治市壺關縣人民醫院 · 內一科

擅長:腫瘤內科治療的臨床工作及轉化研究?

內一科主任醫師

元氏縣醫院 · 內一科

擅長:腫瘤內科治療的臨床工作及轉化研究?

主站蜘蛛池模板: √新版天堂资源在线资源| 内射少妇一区27p| 好大好深好猛好爽视频免费| 欧美性猛交xxxx乱大交蜜桃| 亚洲色图片区| 中文字幕 欧美 亚洲| 丰满熟妇hd| 亚洲日韩成人无码| 极品少妇被弄得高潮不断| 亚洲国产精品无码久久久| 青草青草久热精品视频在线观看| caoporn成人免费公开| 精品人妻少妇一区二区| 熟妇人妻系列aⅴ无码专区友真希| 永久黄网站色视频免费| 宝贝腿开大点我添添公视频免| 国产乱子伦真实| 日欧137片内射在线视频播放| 中文字幕mv在线观看| 大地影院高清在线观看免费使命| 久久久人人人婷婷色东京热| 久久99国产综合精品免费| 蜜桃成熟时快播| 两个人的视频全免费观看在线| 欧美老肥妇做爰bbww| 99久久久无码国产精品性| 国产国语对白露脸正在播放| 久久久国产精品黄毛片| 国产69精品久久久久人妻| 国产在线精品国自产拍影院同性| 丰满熟妇videosxxxxx| 粉色视频播放| 老外女人毛黑p大| 国产肥白大熟妇bbbb视频| 亚洲丶国产丶欧美一区二区三区| 日韩av一中美av一中文字慕| 大地资源二在线视频观看| a毛片免费全部播放| www.夜夜操.com| 最新亚洲人成无码网www电影| 丰满少妇a级毛片|